109 related articles for article (PubMed ID: 11368382)
1. Marrow vs peripheral blood: impact on transplant outcome.
Forman SJ
Leukemia; 2001 Apr; 15(4):686-7. PubMed ID: 11368382
[No Abstract] [Full Text] [Related]
2. Selecting unrelated donor grafts to prevent leukaemia relapse.
Szabolcs P
Lancet Oncol; 2010 Jul; 11(7):608-9. PubMed ID: 20558105
[No Abstract] [Full Text] [Related]
3. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.
Basara N; Blau WI; Kiehl MG; Römer E; Rudolphi M; Bischoff M; Kirsten D; Sanchez H; Günzelmann S; Fauser AA
Transplant Proc; 1998 Dec; 30(8):4087-9. PubMed ID: 9865306
[No Abstract] [Full Text] [Related]
5. Immune recovery after bone marrow and peripheral blood stem cells transplantation.
Marin GH; Mendez MC; Menna ME; Malacalza J; Bergna MI; Klein G; Italiano C; Perez M; Gil MA; Gardenal L; Mansilla E; Orlando S; Saba S; Cánepa C; Piccinelli G
Transplant Proc; 1999 Sep; 31(6):2582-4. PubMed ID: 10500728
[No Abstract] [Full Text] [Related]
6. [Transplantation of hematopoietic stem cells].
Hertenstein B; Novotny J; Ebell W; Ganser A
Internist (Berl); 1996 Mar; 37(3):295-303. PubMed ID: 8919947
[No Abstract] [Full Text] [Related]
7. Blood cell and bone marrow transplants.
Lazarus HM; Gale RP
Bone Marrow Transplant; 1996 Nov; 18(5):839-41. PubMed ID: 8932834
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
[TBL] [Abstract][Full Text] [Related]
9. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
[TBL] [Abstract][Full Text] [Related]
10. [Graft-versus-leukemia reactions].
Ju X; Wang J
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):443-5. PubMed ID: 11721426
[No Abstract] [Full Text] [Related]
11. [Current status and issues in hematopoietic stem cell transplantation].
Harada M
Fukuoka Igaku Zasshi; 2007 Feb; 98(2):35-47. PubMed ID: 17396570
[No Abstract] [Full Text] [Related]
12. [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].
Nguyen S; Chalandon Y; Lemarie C; Simon S; Masson D; Dhedin N; Suarez F; Renaud B; Charbonnier A; Yafour N; François S; Duléry R; Blaise D; Yakoub-Agha I; Rubio MT
Bull Cancer; 2016 Nov; 103(11S):S229-S242. PubMed ID: 27842860
[TBL] [Abstract][Full Text] [Related]
13. Cellular engineering through marrow transplantation.
Good RA; Kapoor N; Day NK; Reisner Y
Prog Clin Biol Res; 1984; 149():271-98. PubMed ID: 6146143
[No Abstract] [Full Text] [Related]
14. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
[TBL] [Abstract][Full Text] [Related]
15. [Value of hematopoietic stem cell transplantation in treatment of leukemia].
Runde V; Schaefer UW
Internist (Berl); 1996 Oct; 37(10):1030-9. PubMed ID: 9019447
[No Abstract] [Full Text] [Related]
16. Improved outcomes using G-CSF-mobilized blood and bone marrow grafts as the source of stem cells compared with G-PB after HLA-identical sibling transplantation in patients with acute leukemia.
Zhao XS; Chen Y; Zhao XY; Liu DH; Xu LP; Wang Y; Han W; Chen YH; Chen H; Zhang XH; Liu KY; Huang XJ
Clin Transplant; 2013; 27(6):844-51. PubMed ID: 23992032
[TBL] [Abstract][Full Text] [Related]
17. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
Rocha V; Labopin M; Sanz G; Arcese W; Schwerdtfeger R; Bosi A; Jacobsen N; Ruutu T; de Lima M; Finke J; Frassoni F; Gluckman E; ;
N Engl J Med; 2004 Nov; 351(22):2276-85. PubMed ID: 15564544
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
Basara N; Kiehl MG; Blau W; Römer E; Bischoff M; Schmetzer B; Kirsten D; Günzelmann S; Fauser AA
Transplant Proc; 2001 May; 33(3):2121-3. PubMed ID: 11377471
[No Abstract] [Full Text] [Related]
19. Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
Byrne JL; Stainer C; Hyde H; Miflin G; Haynes AP; Bessell EM; Russell NH
Bone Marrow Transplant; 1998 Sep; 22(6):541-5. PubMed ID: 9758340
[TBL] [Abstract][Full Text] [Related]
20. Quest to improve marrow transplant success yields new approaches to graft-vs-host disease.
Kirn TF
JAMA; 1987 Sep; 258(11):1438-9. PubMed ID: 3306001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
